文献速递多重用药

2020年Medicare Part D人群中Beers标准药物使用率分析

Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020.
PubMed 文献 · J Am Geriatr Soc · 2024-05-06

该研究基于2020年Medicare Part D提供者使用与支付公共数据,评估65岁及以上人群中2019版Beers标准药物的使用率。

要点

  • 总体16%的Part D处方为潜在不适当药物,苯二氮䓬类是最常使用的「避免」类药物。

核心结论

  • 尽管AGS Beers标准持续更新,2020年Medicare Part D中仍有16%的处方为潜在不适当药物。

研究设计与样本

  • 基于2020日历年Medicare Part D提供者使用与支付公共使用文件的分析。
  • 将2019版Beers标准药物应用于分析,分为「避免」和「谨慎使用」两类评估。

主要发现

  • 「避免」类中最常使用的药物类别为苯二氮䓬类(25,949,994张)、Z类药物(6,204,909张)、长效磺脲类(5,306,577张)、第一代抗组胺药(5,049,289张)和三环类抗抑郁药(4,190,062张)。
  • 「谨慎使用」类中最常使用的药物为利尿剂(74,599,126张)、选择性5-羟色胺再摄取抑制剂(30,033,121张)、5-羟色胺和去甲肾上腺素再摄取抑制剂(11,858,968张)、曲马多(11,450,878张)和米氮平(5,737,304张)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medication utilization has been increasing in the U.S. year-over-year for several decades. As older adults take more medications, there is a higher risk of them being exposed to drug-drug or drug-disease interactions. The American Geriatrics Society in 2019 updated their Beers Criteria for Potentially Inappropriate Medication (PIM) Use in Older Adults. The objective of this study was to assess the prevalence of utilization of medications included in the 2019 Beers Criteria. METHODS: An analysis was conducted using the Medicare Part D Provider Utilization and Payment Data Public Use File for calendar-year 2020. Medications identified in the 2019 Beers Criteria were applied to the analysis. Two categories of medications were assessed: (1) "Avoid" and (2) "Use With Caution." RESULTS: In 2020, 56 million prescriptions were dispensed to Medicare patients 65 years and older that are recommended to be avoided without exception (4.7% of all prescriptions) totaling $957 million in medication costs. The most utilized medication classes in this category were benzodiazepines (25,949,994 prescriptions), "Z-drugs" (6,204,909 prescriptions), long-acting sulfonylureas (5,306,577 prescriptions), 1st-generation antihistamines (5,049,289 prescriptions), and tricyclic antidepressants (4,190,062 prescriptions). Additionally, 135 million prescriptions were dispensed to Medicare beneficiaries 65 years and older for medications which the Beers Criteria states to use caution (11.3% of all prescriptions) exceeding $2.85 billion in medication costs. The most utilized medications for this category were diuretics (74,599,126 prescriptions), selective serotonin reuptake inhibitors (30,033,121 prescriptions), serotonin and norepinephrine reuptake inhibitors (11,858,968 prescriptions), tramadol (11,450,878 prescriptions), and mirtazapine (5,737,304 prescriptions). CONCLUSION: Even with the existence of the AGS Beers Criteria for PIM Use in Older Adults and its continued updated versions, 16% of medications dispensed to Medicare Part D were potentially inappropriate. Future studies are needed to assess if this has led to worsened outcomes among older adults who utilized these PIM.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Borrelli EP. Assessing the prevalence of Beers medication utilization in the Medicare Part D population in 2020. J Am Geriatr Soc. 2024. PMID: 38709112. doi:10.1111/jgs.18943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。